Stone Toro Investment Advisers’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-8,900
Closed -$564K 162
2013
Q3
$564K Buy
+8,900
New +$564K 0.37% 66